Michael Betel

Patient Advocacy Committee Co-chair: The Global NASH Council was created to include renowned experts from different regions of the world with interest in NASH/MASH to collaborate and exchange their views about this liver disease. Global NASH Council include 63 countries from all the continents across the globe with 294 members. Members of the Council carry out collaborative projects to better understand the burden of NASH/MASH across the globe.

Peer reviewer: Communications Medicine. July 2024.

"We bring together healthcare professionals, researchers, policymakers and people with lived experience to drive recognition, prevention, diagnosis, and equitable care of steatotic liver disease (SLD)—with a focus on metabolic dysfunction-associated SLD (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)."

In 2021, GLI launched the Liver Action Network (LAN) to meet the rapidly growing need for a coalition of community based organizations across the United States and abroad. Collectively, the LAN facilitates grassroot efforts to advance liver policy at the local, state, national and international levels. The LAN is an affiliation model that facilitates strategic mentorship, technical assistance, and financial support to community organization members, and affords a central structure for the… Visualizza altro

In 2021, GLI launched the Liver Action Network (LAN) to meet the rapidly growing need for a coalition of community based organizations across the United States and abroad. Collectively, the LAN facilitates grassroot efforts to advance liver policy at the local, state, national and international levels. The LAN is an affiliation model that facilitates strategic mentorship, technical assistance, and financial support to community organization members, and affords a central structure for the formulation of policy positions and programmatic solutions by advocates. LAN is a first-of-its-kind network that provides community member organizations a central structure for the formulation of collective policy positions and programmatic solutions. Meno dettagli

The Global NASH Council ™ has been formed to bring together international experts to discuss, collaborate and contribute to the field of NASH. Given the global nature of NAFLD and NASH, it is important to include perspectives from different regions of the world, assess the clinical and economic impact of NASH which are based on the realities of each country and region.

* Member of the Patient Advisory Committee.
* Member of Hepatology Non-Hepatology Interface Committee.

We share goals to raise awareness, advocate for treatment access, and support research to beat Steatotic Liver Disease. Together, we envision a future where this condition is preventable, and every patient in need has access to the best tailored care possible.

The American College of Radiology is sponsoring a committee for the development of management recommendations for incidental findings.

Grant reviewer

This project aims to generate system-level insights into how Canada’s health care system is prepared to deliver emerging disease-modifying therapies (DMTs) for metabolic dysfunction-associated steatohepatitis (MASH).

Collaborator on the Fatty Liver Disease Research and Action Priorities consensus statement.

Canadian Obesity Advocacy Network (COAN) member.

The Canadian Obesity Advocacy Network (COAN) is a diverse group of organizations that have come together with the purpose of changing the narrative of obesity in Canada. Participants include health professional associations committed to addressing obesity issues, education, and advocacy.

I participated in 4 Delphi sessions, one in-person 2 days workshop as part of the process of consensus statement development for the nomenclature of NAFLD.

Our aim is to produce a consensus statement on the current and potential future nomenclature of NAFLD based on input from a broad, multidisciplinary, global panel of experts. We anticipate some 40-45 statements across key categories (assessment of current nomenclature; stigma associated with aspects of the nomenclature; evaluation of… Visualizza altro

I participated in 4 Delphi sessions, one in-person 2 days workshop as part of the process of consensus statement development for the nomenclature of NAFLD.

Our aim is to produce a consensus statement on the current and potential future nomenclature of NAFLD based on input from a broad, multidisciplinary, global panel of experts. We anticipate some 40-45 statements across key categories (assessment of current nomenclature; stigma associated with aspects of the nomenclature; evaluation of the role of alcohol as a disease cofactor; assessment of impact of a name change on therapeutic development; assessment of the impact of a name change on disease awareness; assessment of MAFLD as an acceptable nomenclature to replace NAFLD; assessment of alternate names to replace NAFLD). Meno dettagli

The European Association for the Study of the Liver (EASL), under the umbrella of Healthy Livers, Healthy Lives: A Global Coalition for Action on Fatty Liver Disease, in the development of a global fatty liver disease research and action priorities agenda.

This global coalition will act as a platform for collective thinking and action. While EASL is coordinating this effort, the global coalition will be a collective effort led by the major liver associations.

Helping the Ottawa chapter raise much needed funds in 2020.

Received 50th Anniversary Recognition medal for long-standing service to community (2019).
Received Certificate of Appreciation in recognition for LIVERight Gala Guest Speaker (2019)

The CLF mandate is to promote liver health and reduce the incidence and impact of liver disease by providing support for research and education into the causes, diagnoses, prevention and treatment of liver disease.

As a Member of the Board of Directors, and a member of the National Marketing &… Visualizza altro

Received 50th Anniversary Recognition medal for long-standing service to community (2019).
Received Certificate of Appreciation in recognition for LIVERight Gala Guest Speaker (2019)

The CLF mandate is to promote liver health and reduce the incidence and impact of liver disease by providing support for research and education into the causes, diagnoses, prevention and treatment of liver disease.

As a Member of the Board of Directors, and a member of the National Marketing & Communications Committee and the Strategy Committee, I advised and assisted The Canadian Liver Foundation with the mandate to promote liver health and reduce the incidence and impact of liver disease by providing support for research and education into the causes, diagnoses, prevention and treatment of liver disease. Meno dettagli

Fabulous leadership opportunity to work with community children, building their confidence and skillsets in a sports setting.